Life sciences and healthcare companies that set out to pioneer treatments in rare and specialty disease face a unique set of challenges. Typical pitfalls for advancing an indication in this space...

Nitin Choudhary, Managing Principal of IPM.ai and Richard Wilson, Rare Disease Franchise Head for Kyowa Kirin recently spoke on overcoming patient-finding challenges through machine learning (ML)...

Conventional clinical study recruitment methods for rare diseases simply don’t work. Analyzing ICD-10 and prescription data to determine patient clusters, site selection and feasibility is...

October 7, 2021

Building a Rare Disease Franchise with Machine Learning and Artificial...

0

Nitin Choudhary, Managing Principal of IPM.ai and Richard Wilson, Rare Disease Franchise Head for Kyowa Kirin recently spoke on overcoming patient-finding challenges through machine learning (ML)...

September 29, 2021

A New Reference Model for Clinical Study Recruitment

0

Conventional clinical study recruitment methods for rare diseases simply don’t work. Analyzing ICD-10 and prescription data to determine patient clusters, site selection and feasibility is...

August 19, 2021

Real Chemistry's IPM.ai Expands Partnership with Datavant

0

San Francisco – Aug. 19, 2021 – Real Chemistry’s IPM.ai, the leader in uncovering undiagnosed and misdiagnosed patients via machine learning, and Datavant, the leader in helping healthcare and...

July 29, 2021

IPM.ai Accelerates the Clinical Study and Commercialization of Precision...

0

Targeted Approach Optimizes Clinical Study Recruitment of Medically-Eligible Patients Affected by Rare Diseases

July 13, 2021

John Garcia of Alnylam Discusses Finding Patients With Rare Disease

0

Challenges are an inevitability when building a drug portfolio in the rare disease space, and patient finding is no doubt chief among them. Clinical trial recruitment is highly capital intensive,...

January 19, 2021

IPM.ai and Momenta at the 62nd Annual ASH Meeting

0

Our own Julie Gubitosa and Graham Jones accompanied by Keith R. McCrae, MD of the Cleveland Clinic and Jennifer Beachell, Tricia Gooljarsingh PhD and Mary Lee Tjoa of Momenta Pharmaceutical,...

October 11, 2020

Swoop Partners With IPM.ai for Pharmaceutical Ad Optimization

0

Real World Data and Social Determinants of Health can now be used for precision cross-channel pharmaceutical marketing campaigns